Dr. Gerald Diaz @GeraldMD
48.6M 14.2K 7.5K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief πŸ‡΅πŸ‡­ πŸ‡ΊπŸ‡Έ - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
13 results
management infections opportunistic prevention blockers mycobacterium 2016 aace aafp agents antiarrhythmics aviumcomplex beta candida candidiasis capsulatum cessation channel classi cmv
Pharmacologic Treatment of Hyperthyroidism #Hyperthyroidism #Treatment #Management #Pharmacology #Medications #Comparison #Table #Endocrinology #AAFP #Propylthiouracil #Methimazole
Pharmacologic Treatment ... Hyperthyroidism #Treatment ... #Management #Pharmacology ... #Medications #Comparison ... #Table #Endocrinology
β–Ί
 FDA-Approved 1st line Medications for Tobacco Cessation Treatment Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
FDA-Approved 1st line Medications ... Tobacco Cessation Treatment ... ) #Pharmacology ... Cessation #Therapy #Comparison ... #Table #Agents
Table of Weight-Loss Medications approved by the FDA for the long-term treatment of Obesity Mechanism of Action,
Table of Weight-Loss ... Medications approved ... the long-term treatment ... WeightLoss #AACE #2016 #Pharmacology ... #Table #Comparison
Beta Blockers - Pharmacology Comparison Table Metoprolol: β€’ Receptors: Ξ²1 β€’ Indications: Rate control of a-fib/a-flutter, Suppression
Beta Blockers - Pharmacology ... Comparison Table ... Beta #Blockers #Pharmacology ... #Comparison #Table ... #Receptors #cardiology
Antiarrhythmics - Sodium Channel Blockers Subclasses, Mechanisms, Indications, Side Effects la - Quinidine, Procainamide lb - Lidocaine, Mexiletine Ic -
Subclasses, Mechanisms, Indications ... Blockers #ClassI #Na #cardiology ... #pharmacology # ... table #comparison
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
IDSA Recommendations ... mucoadhesive buccal tablet ... chew, or crush tablet ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS Indications for Initiating Primary Prophylaxis: β€’
IDSA Recommendations ... #Encephalitis #IDSA ... #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS Indications for Initiating Primary Prophylaxis: β€’
IDSA Recommendations ... with ARV (see Table ... #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS Preventing CMV Disease: β€’ CMV end-organ disease is best
IDSA Recommendations ... ., concomitant medications ... Cytomegalovirus #CMV #IDSA ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS Pre-Exposure Prevention of VZV
IDSA Recommendations ... Primary Infection Indications ... #Zoster #VZV #IDSA ... opportunistic #infections #HIVAIDS ... #pharmacology
empty